Resolution of in flammation: state of the art, definitions and terms
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
A recent focus meeting on Controlling Acute Inflammation was held in London, April 27–28, 2006, organized by D.W. Gilroy and S.D. Brain for the British Pharmacology Society. We concluded at the meeting that a consensus report was needed that addresses the rapid progress in this emerging field and details how the specific study of resolution of acute inflammation provides leads for novel anti‐inflammatory therapeutics, as well as defines the terms and key components of interest in the resolution process within tissues as appreciated today. The inflammatory response protects the body against infection and injury but can itself become dysregulated with deleterious consequences to the host. It is now evident that endogenous biochemical pathways activated during defense reactions can counter‐regulate inflammation and promote resolution. Hence, resolution is an active rather than a passive process, as once believed, which now promises novel approaches for the treatment of inflammation‐associated diseases based on endogenous agonists of resolution.—Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., Wallace, J. L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325–332 (2007)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The process of inflammation resolution involves not only passive mechanisms, e.g., dissipation of chemotactic gradient or initial danger signals, but also active biochemical pathways [103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“These lipid mediators can selectively stop neutrophil infiltration; increase monocyte recruitment and macrophage phagocytosis; stimulate the expression of genes important for antimicrobial defense; and promote the exit of phagocytes from the inflamed sites [100–103].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [103]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326 · cited 3×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
Background(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 2×
“1C), may lead to prolonged inflammation and the inability for the tissue to return to homeostasis (26) and complete the full life-cycle per se of the neutrophils and mononuclear cells recruited to the tissue.”
BackgroundSelf-citationAgostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768 · cited 1×
“Nalp3 occurs in an inflammasome complex with caspase-1, ASC, cardinal, and Nalp2 ( 12 ).”
BackgroundMolecular identification of a danger signal that alerts the immune system to dying cells
Shi, Y., Evans, J. E., & Rock, K. L. (2003) · Nature · doi:10.1038/nature01991 · Cited by 1,684 · cited 1×
“Uric acid is the causative agent of gout but is also released by damaged cells, possibly as a general signal for inflammation (15).”
BackgroundSerhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650 · cited 1×
“Additionally, the widely used aspirin jump-starts resolution by making up for its loss in prostaglandin production, which plays key roles in resolution, by instead generating the epimeric version of lipid mediators (25), such as the aspirin-triggered lipoxins (recently reviewed in ref.”
BackgroundSelf-citationNegative regulation of Toll-like receptor-mediated immune responses
Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1630 · Cited by 1,509 · cited 8×
“In effect, TLRs sow the seeds of their own destruction, and the role of negative regulators clearly indicates how robust the TLR system is.”
BackgroundInfluentialSelf-citationLipid mediator class switching during acute inflammation: signals in resolution
Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N. (2001) · Nature Immunology · doi:10.1038/89759 · Cited by 1,453 · cited 1×
“enzymes are expressed (31), and whether it is resolving”
BackgroundSelf-citationRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401 · cited 4×
“TLRs and NLRs also sense products of inflamed tissue, and notable examples are the sensing of low MW hyaluronic acid fragments by TLR2 and TLR4 (13) and the sensing of uric acid by Nalp3 (14).”
BackgroundInfluentialInducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Self-citation
Cited by
Items 701–800 of 1,000
12/15-Lipoxygenase choreographs the resolution of IgG-mediated skin inflammation
Sezin, T., Ferreirós, N., Jennrich, M., Ochirbold, K., Seutter, M., Attah, C., Mousavi, S., Zillikens, D., Geißlinger, G., & Sadik, C. D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102528 · Cited by 18
Gonçalves, L. U., Cortegano, C. A. A., Barone, R. S. C., Lorenz, E. K., & Cyrino, J. E. P. (2021) · Aquaculture Research · doi:10.1111/are.15536 · Cited by 17
Pateras, I. S., Igea, A., Nikas, I. P., Leventakou, D., Koufopoulos, N. I., Ieronimaki, A. I., Bergonzini, A., Ryu, H. S., Chatzigeorgiou, A., Frisan, T., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021251 · Cited by 21
“To effectively mitigate the acute inflammatory response, proinflammatory signaling pathways are counterbalanced by anti-inflammatory mediators that favor the return of homeostasis [2].”
BackgroundDownstream Gene Activation of the Receptor ALX by the Agonist Annexin A1
Renshaw, D. W., Montero‐Melendez, T., Dalli, J., Kamal, A. M., Brancaleone, V., D’Acquisto, F., Cirino, G., & Perretti, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012771 · Cited by 20
“rapid regain of homeostasis [1,2,3,4].”
Self-citationTomkins‐Lane, C., Lafave, L. M. Z., Parnell, J. A., Krishnamurthy, A., Rempel, J., Macedo, L. G., Moriartey, S., Stuber, K. J., Wilson, P. M., Hu, R. W., et al. (2013) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-14-322 · Cited by 20
“Physical inactivity and accompanying weight gain increase the risk of many chronic diseases, notably obesity, metabolic syndrome, coronary heart disease, type 2 diabetes, and certain cancers [9-22].”
BackgroundMastromarino, M., Favia, M., Schepetkin, I. A., Kirpotina, L. N., Trojan, E., Niso, M., Carrieri, A., Leśkiewicz, M., Regulska, M., Darida, M., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c02203 · Cited by 18
Reduced lipoxygenase and cyclooxygenase mediated signaling in PBMC of atopic dermatitis patients
Mihály, J., Gericke, J., Törőcsik, D., Gáspár, K., Szegedi, A., & Rühl, R. (2013) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2013.03.003 · Cited by 19
Urrutia, R. A., & Kalinec, F. (2015) · Hearing Research · doi:10.1016/j.heares.2015.04.015 · Cited by 18
“The anti-inflammatory program ends with the departure of macrophages through lymphatic vessels (Serhan et al., 2008, 2007).”
BackgroundZahoor, I., Nematullah, M., Ahmed, M. E., Fatma, M., Sajad, M., Ayasolla, K., Cerghet, M., Palaniyandi, S. S., Ceci, V., Carrera, G., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108226 · Cited by 21
CX3CL1(+) Microparticles-Induced MFG-E8 Enhances Apoptotic Cell Clearance by Alveolar Macrophages
Tsai, W.-H., Chang, S.-C., Lin, Y.-C., & Hsu, H.-C. (2021) · Cells · doi:10.3390/cells10102583 · Cited by 16
“Attenuation of the effects of pro-inflammatory mediators assists in the successful ‘switching off’ of inflammation when sufficient numbers of cells have been recruited into alveolar spaces [17].”
BackgroundResolvin D2 Supports MCF-7 Cell Proliferation via Activation of Estrogen Receptor
Al-Zaubai, N., Johnstone, C. N., Leong, M. M., Li, J., Rizzacasa, M. A., & Stewart, A. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214403 · Cited by 16
“Resolution of inflammation, previously believed to take place passively, is now considered an actively programmed process distinct from anti-inflammatory processes, enabling the host tissue to return to homeostasis (Serhan et al., 2007).”
BackgroundDasilva, G., Lois, S., Méndez, L., Miralles‐Pérez, B., Romeu, M., Ramos-Romero, S. O., Torres, J. L., & Medina, I. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.608875 · Cited by 17
“They coordinately act to regulate epithelial, endothelial, and immune cell function for the restoration of homeostasis in a specific time-limited manner (11).”
BackgroundHaddad, L. E., & Sirois, M. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088980 · Cited by 16
“oxide (NO) and Ang2 while increasing stabilizing elements such as Ang1 (resolution reviewed in [47];[48]).”
BackgroundThe Multicomponent Medication Lymphomyosot Improves the Outcome of Experimental Lymphedema
Keim, A., Slis, J. R., Mendez, U., Stroup, E. M., Burmeister, Y., Tsolaki, N., Gailing, O., & Goldman, J. (2013) · Lymphatic Research and Biology · doi:10.1089/lrb.2012.0024 · Cited by 17
Barbon, C. M., Baker, L., Lajoie, C., Ramstedt, U., Hedley, M. L., & Luby, T. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.078 · Cited by 19
Wolfer, A. M., Scott, A. J., Rueb, C., Gaudin, M., Darzi, A. W., Nicholson, J. K., Holmes, E. C., & Kinross, J. K. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1171-2 · Cited by 15
Tarannum, F., & Faizuddin, M. (2017) · Brazilian Dental Journal · doi:10.1590/0103-6440201701094 · Cited by 16
Crowe, W. E., Allsopp, P. J., Nyland, J. F., Magee, P. J., Strain, J., Doherty, L. C., Watson, G. E., Ball, E., Riddell, C., Armstrong, D., et al. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.05.008 · Cited by 17
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 19
Anti-Inflammatory Effects of Lipoxins on Lipopolysaccharide-Induced Uveitis in Rats
Karim, M. J., Bhattacherjee, P., Biswas, S., & Paterson, C. A. (2009) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2008.0134 · Cited by 16
Retina regeneration: lessons from vertebrates
Sharma, P., & Ramachandran, R. (2022) · Oxford Open Neuroscience · doi:10.1093/oons/kvac012 · Cited by 16
“But dysregulation of inflammation can lead to chronic inflammation, which is harmful to injured tissue and does not culminate in regeneration [118].”
BackgroundPeña, N. O., Cherukula, K., Even, B., Ji, D., Razafindrakoto, S., Peng, S., Silva, A., Ménard‐Moyon, C., Hillaireau, H., Bianco, A., et al. (2023) · Advanced Materials · doi:10.1002/adma.202209615 · Cited by 15
Ginsenoside Rk3 Ameliorates Obesity-Induced Colitis by Modulating Lipid Metabolism in C57BL/6 Mice
Wang, W., Chen, H., Zhang, W., Fan, D., Deng, J., & Yang, H. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08253 · Cited by 17
Nasoohi, S., Hemmati, A. A., Moradi, F., & Ahmadiani, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.051 · Cited by 17
Epigenetic regulation of the formyl peptide receptor 2 gene
Simiele, F., Recchiuti, A., Patruno, S., Plebani, R., Pierdomenico, A. M., Codagnone, M., & Romano, M. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.07.007 · Cited by 15
The role of lipoxin in regulating tumor immune microenvironments
Zhang, T., Hao, H., & Zhou, X. (2019) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2019.106341 · Cited by 16
Preethanath, R. S., Ibraheem, W., & Anil, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91614 · Cited by 22
Information generation and processing systems that regulate periodontal structure and function
Bartold, P. M., & McCulloch, C. A. (2013) · Periodontology 2000 · doi:10.1111/prd.12037 · Cited by 16
Resolving lung injury: a new role for Tregs in controlling the innate immune response
Pietropaoli, A. P., & Georas, S. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40880 · Cited by 15
Abdalla, H. B., Napimoga, M. H., de Macedo, C. G., Bonfante, R., de Araújo, D. R., de Melo, N. F. S., Carvalho, L. B., Fraceto, L. F., & Clemente‐Napimoga, J. T. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119383 · Cited by 15
[The essential fatty acids omega-6 and omega-3: from their discovery to their use in therapy].
Caramia, G. (2008) · PubMed · Cited by 22
Annamalai, P., & Thangam, E. B. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115583 · Cited by 18
Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents
Montanaro, G., Bertinaria, M., Rolando, B., Fruttero, R., Lucas, C. D., Dorward, D. A., Rossi, A. G., Megson, I. L., & Gasco, A. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.01.009 · Cited by 14
Self-citationA New Perspective on Cancer Therapy: Changing the Treaded Path?
Baidoo, J., Mukherjee, S., Kashfi, K., & Banerjee, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189836 · Cited by 14
“Commonly known mediators of inflammation are tumor necrosis factor (TNF) and interleukins [66] and the lipid mediators eicosanoids and thromboxanes [67,68], which signal during the onset phase of inflammation after a trauma or tissue injury [69], thereby increasing vascular permeability, promoting infiltration of neut…”
BackgroundLipid Mediators in Inflammation
Bennett, M., & Gilroy, D. W. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch19 · Cited by 22
Self-citationInnate immunity in surgical patients.
Lacatus, M. (2013) · PubMed · Cited by 14
Tomaiuolo, M., Kottke, M. A., Matheny, R. W., Reifman, J., & Mitrophanov, A. Y. (2016) · Molecular BioSystems · doi:10.1039/c5mb00456j · Cited by 15
The role of lipids in corneal diseases and dystrophies: a systematic review
Rowsey, T. G., & Karamichos, D. (2017) · Clinical and Translational Medicine · doi:10.1186/s40169-017-0158-1 · Cited by 22
“RVs are endogenous, potent, local acting molecules classified as non-classical Eicosanoids [18, 53].”
BackgroundCytokines et inflammation : physiologie, physiopathologie et utilisation thérapeutique
Noack, M., & Kolopp‐Sarda, M. (2018) · Revue Francophone des Laboratoires · doi:10.1016/s1773-035x(18)30052-2 · Cited by 23
Kuret, T., Lakota, K., Mali, P., Čučnik, S., Praprotnik, S., Tomšič, M., & Sodin‐Šemrl, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195346 · Cited by 15
Cilibrizzi, A., Crocetti, L., Giovannoni, M. P., Graziano, A., Vergelli, C., Bartolucci, G., Soldani, G., Quinn, M. T., Schepetkin, I. A., & Faggi, C. (2013) · Chirality · doi:10.1002/chir.22162 · Cited by 14
“The inflammatory response requires tight regulation and control to avoid overshooting, prolongation, and self-induced damage.(2) Considering that most currently used anti-inflammatory drugs have important limitations,(3) the extensive search to find immunomodulatory agents that regulate innate immune responses represe…”
BackgroundNauseef, W. M., & Clark, R. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00008-4 · Cited by 13
Resolution Pharmacology: State-of-the-art and therapeutic landscape
Perretti, M., & Montero‐Melendez, T. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100097 · Cited by 16
Self-citationNguyen, T. U., Payan, B. A., Zambrano, A., Du, Y., Bondesson, M., & Mohan, C. (2019) · Journal of Inflammation Research · doi:10.2147/jir.s224834 · Cited by 13
Lipoxins and their relationship with inflammation-associated diseases. A systematic review
Serna-Orozco, M. F., Mosquera, M., & García‐Perdomo, H. A. (2023) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2023.06.001 · Cited by 14
Nguyen, H. T., Pham‐The, H., Tuan, A. N., Hà, N. T. T., Thi, T. A. D., Le-Nhat-Thuy, G., Thị, P. H., Thi, Q. G. N., & Nguyen, T. V. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129714 · Cited by 14
Ansari, A. R., Li, N.-Y., Sun, Z.-J., Huang, H., Zhao, X., Cui, L., Hu, Y., Zhong, J., Karrow, N. A., & Liu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19964 · Cited by 16
Periodontal Stem Cells Synthesize Maresin Conjugate in Tissue Regeneration 3
Rakian, A., Rakian, R., Shay, A. E., Serhan, C. N., & Dyke, T. E. V. (2022) · Journal of Dental Research · doi:10.1177/00220345221090879 · Cited by 14
“SPMs include the lipoxins, resolvins, protectins, and maresins, which exhibit multipronged actions that improve the outcome of inflammation-related pathologies in experimental models and clinical trials (Serhan et al. 2007; Colas et al. 2014; Van Dyke et al. 2015; Cianci et al. 2016).”
BackgroundSelf-citationEffect of toll-like receptor activation on thymosin beta-4 production by chicken macrophages
Kannan, L., Rath, N. C., Liyanage, R., & Lay, J. O. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0528-0 · Cited by 14
“show increase in their secretory activities [ 33 ].”
BackgroundGravius, S., Randau, T. M., Casadonte, R., Kriegsmann, M., Friedrich, M. J., & Kriegsmann, J. (2014) · International Orthopaedics · doi:10.1007/s00264-014-2544-2 · Cited by 13
“Annexin A1 is one of the effectors of endogenous anti-inflammation and contributes to control mechanisms of cell activation and cell-cell trafficking [37].”
BackgroundIida, J., ISHII, S., Nakajima, Y., Sessler, D. I., Teramae, H., Kageyama, K., Maeda, S., Anada, N., Shibasaki, M., Sawa, T., et al. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.03.040 · Cited by 13
Sammari, H., Jedidi, S., Selmi, H., Jridi, M., Ayari, A., & Sebaï, H. (2024) · Dose-Response · doi:10.1177/15593258241226890 · Cited by 12
COVID-19 and cancer: start the resolution!
Barksdale, C., Kipper, F. C., Tripathy, S., Subbian, S., Serhan, C. N., & Panigrahy, D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10017-z · Cited by 14
Self-citationTargeting stromal cells in chronic inflammation.
Filer, A. D., Raza, K., Salmon, M., & Buckley, C. D. (2007) · PubMed · Cited by 18
Self-citationHomann, J., Suo, J., Schmidt, M., de Bruin, N. M. W. J., Scholich, K., Geißlinger, G., & Ferreirós, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143141 · Cited by 13
Abd-Elghafour, B. A., El-Sayed, N. M., Ahmed, A. A. M., Zaitone, S. A., & Moustafa, Y. M. (2016) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2016-0060 · Cited by 13
Pro-resolution therapeutics for cardiovascular diseases
Heinz, J., Marinello, M., & Fredman, G. (2017) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2017.03.004 · Cited by 13
Wang, L., Yang, H., Yan, H., Ge, R., Wang, Y.-X., Xue, S., Li, L., Lyu, L., & Che, C. (2022) · Current Medical Science · doi:10.1007/s11596-022-2512-9 · Cited by 12
Ferreirós, N., Homann, J., Labocha, S., Grossmann, N., Hahn, J. S., Brüne, B., & Geißlinger, G. (2014) · Talanta · doi:10.1016/j.talanta.2014.03.051 · Cited by 12
Specialized pro‐resolving mediators: wiring the circuitry of effector immune and tissue homeostasis
Fredman, G., & Serhan, C. N. (2011) · Endodontic Topics · doi:10.1111/etp.12010 · Cited by 13
Self-citationCyclic GMP protects human macrophages against peroxynitrite-induced apoptosis
Shaw, C. A., Webb, D. J., Rossi, A. G., & Megson, I. L. (2009) · Journal of Inflammation · doi:10.1186/1476-9255-6-14 · Cited by 17
“Resultant MDMφ were treated for 24 h with DETA/NO (100 – 1000 μM) or GEA-3162 (10 – 300 μM) in the presence or absence of BAY 41–2272 (1 μM), isobutylmethylxanthine (IBMX; 1 μM), 1H- [1,2,4]oxadiazolo [4,3-a]quinoxalin-1-one (ODQ; 20 μM) or 8-bromo-cGMP (1 mM).”
Self-citationIt's Complicated: Inflammation from Metchnikoff to Meryl Streep
Weissmann, G. (2010) · The FASEB Journal · doi:10.1096/fj.10-1101ufm · Cited by 12
“(4) The literature is awash in inflammation these days (Table 1).”
BackgroundThe biosynthetic pathways of the protectins
Haatveit, Å. S., & Hansen, T. V. (2023) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2023.106787 · Cited by 12
Lipoxins, resolvins and protectins: new leads for the treatment of asthma
Haworth, O., & Levy, B. D. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.10.1209 · Cited by 12
Mavrommatis, B., Offord, V., Patterson, R., Watson, M., Kanellos, T., Steinbach, F., Grierson, S. S., & Werling, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091081 · Cited by 12
“This result was particularly surprising considering AMØs are among the first innate immune cell to encounter PCV2 in the lung [54] and function in phagocytic clearance, inflammatory reactions and tissue homeostasis [55], but may also be partially affected by the experimental set-up in which cells were exposed to PCV2b…”
ResultExpression and regulation of drug transporters in vertebrate neutrophils
Foulkes, M. J., Henry, K. M., Rougeot, J., Hooper‐Greenhill, E., Loynes, C. A., Jeffrey, P., Fleming, A., Savage, C. O. S., Meijer, A. H., Jones, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04785-4 · Cited by 14
Pineda‐Peña, E. A., Orona-Ortiz, A., Velázquez-Moyado, J. A., Carvalho, J. C. T., Chávez‐Piña, A. E., Balderas-López, J. L., & Navarrete, A. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01857-7 · Cited by 11
Balogh, V., MacAskill, M. G., Hadoke, P. W. F., Gray, G. A., & Tavares, A. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.719031 · Cited by 12
Saviano, A., Vita, S. D., Chini, M. G., Marigliano, N., Lauro, G., Casillo, G. M., Raucci, F., Iorizzi, M., Hofstetter, R. K., Fischer, K., et al. (2022) · Biomolecules · doi:10.3390/biom12010099 · Cited by 11
Pro-resolving and anti-arthritic properties of the MC1 selective agonist PL8177
Garrido‐Mesa, J., Thomas, B. L., Dodd, J. H., Spana, C., Perretti, M., & Montero‐Melendez, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1078678 · Cited by 11
Self-citationAcute Coronary Syndrome May be Associated with Decreased Resolvin D1-to-Leukotriene B4 Ratio
Sun, C., Zheng, W., Liang, L., Zhang, Z., Liu, Z., Sun, W., Zhou, J., Qiao, W., Xie, Q., & Tang, R. (2023) · International Heart Journal · doi:10.1536/ihj.22-361 · Cited by 13
Starinets, A., Tyrtyshnaia, A. A., & Manzhulo, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076273 · Cited by 12
“As previously described, DHA is metabolized into highly active compounds, including resolvins, which actively facilitate the resolving phase of acute inflammation, unlike protein mediators that act during the onset phase of inflammation [13].”
BackgroundStama, M. L., Lacivita, E., Kirpotina, L. N., Niso, M., Perrone, R., Schepetkin, I. A., Quinn, M. T., & Leopoldo, M. (2017) · ChemMedChem · doi:10.1002/cmdc.201700429 · Cited by 11
Gilroy, D. W., & Lawrence, T. (2008) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7506-5_1 · Cited by 20
“This is the ideal sequence of events in physiological inflammation, which contrast to the situation in pathological inflammation (B), where some of the factors that initiate the resolution program lead to the inappropriate accumulation of leukocytes in the wrong place at the wrong time (from [ 69 ]).”
BackgroundSelf-citationEditorial: Gazing forward while looking back
Cassatella, M. A., & Nauseef, W. M. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812424 · Cited by 11
Torres-Vanegas, J., Rodriguez‐Echevarría, R., Campos-Perez, W. Y., Rodríguez-Reyes, S. C., Reyes-Pérez, S. D., Pérez-Robles, M., & Martínez‐López, E. (2025) · Healthcare · doi:10.3390/healthcare13020103 · Cited by 17
“This results in the prolonged presence of immune cells such as lymphocytes, macrophages, and plasma cells in the adipose tissue, accompanied by the secretion of pro-inflammatory cytokines [11,12].”
A soluble form of the CSF-1 receptor contributes to the inhibition of inflammation in a teleost fish
Rieger, A. M., Konowalchuk, J. D., Havixbeck, J. J., Robbins, J. S., Smith, M. K., Lund, J. M., & Barreda, D. R. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.12.001 · Cited by 10
“Please cite this article in press as: Rieger, A.M., et al. A soluble form of the CSF Dev. Comp. Immunol. (2012), http://dx.”
BackgroundLigand Bias and Its Association With Pro-resolving Actions of Melanocortin Drugs
Patruno, S., Garrido‐Mesa, J., Romano, M., Perretti, M., & Montero‐Melendez, T. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00919 · Cited by 10
Self-citationYang, T., & Terrando, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21735-8_4 · Cited by 13
Imaging and Targeting Coronary Artery Inflammation
West, H. W., & Antoniades, C. A. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8128 · Cited by 10
Local inflammatory reaction induced by Scolopendra viridicornis centipede venom in mice
Kimura, L. F., Prezotto-Neto, J. P., Távora, B. D. C. L. F., Antoniazzi, M. M., Knysak, I., Guizze, S. P. G., Santoro, M. L., & Barbaro, K. C. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.10.017 · Cited by 10
“an inflammatory process in order to signal the inflammation, eliminate the offending agent and restore stricken tissue (Galli et al., 2011; Serhan et al., 2007).”
BackgroundComplex roles of cyclo-oxygenase 2 in hepatitis
Holt, A. P., & Adams, D. (2007) · Gut · doi:10.1136/gut.2006.115972 · Cited by 10
Interactions between immune challenges and cancer cells proliferation: timing does matter!
Jacqueline, C. M., Bourfia, Y., Hbid, H., Sorci, G., Frédéric Thomas, A., & Roche, B. (2016) · Evolution Medicine and Public Health · doi:10.1093/emph/eow025 · Cited by 11
Sepsis, Severe Sepsis, and Septic Shock
Munford, R. S., & Suffredini, A. F. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00075-8 · Cited by 19
Khoshbin, E., Salehi, R., Behroozi, R., Sadr, S., Zamani, A., Farhadian, M., & Karkehabadi, H. (2023) · BMC Oral Health · doi:10.1186/s12903-023-03243-0 · Cited by 11
Melanocortin therapies to resolve fibroblast-mediated diseases
Khodeneva, N., Sugimoto, M. A., Davan-Wetton, C. S. A., & Montero‐Melendez, T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1084394 · Cited by 12
Paksoy, T., Ustaoğlu, G., Şehirli, A. Ö., Ünsal, R. B. K., Sayıner, S., Orhan, K., Aycı, N. B., Çetınel, Ş., Aksoy, U., & Öğünç, A. V. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110446 · Cited by 9
Mast Cell-Mediated Inhibition of Abdominal Neutrophil Inflammation by a PEGylated TLR7 Ligand
Hayashi, T., Yao, S., Crain, B., Chan, M., Cottam, H. B., Lao, F. S., Carson, D. A., & Corr, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/262394 · Cited by 9
Resolvin D1 Administration Is Beneficial in Trypanosoma cruzi Infection
Horta, A. L., Williams, T. M., Han, B., Ma, Y., Menezes, A. P. D. J., Tu, V., Talvani, A., Weiss, L. M., & Huang, H. (2020) · Infection and Immunity · doi:10.1128/iai.00052-20 · Cited by 11
Crocetti, L., Vergelli, C., Guerrini, G., Giovannoni, M. P., Kirpotina, L. N., Khlebnikov, А. I., Ghelardini, C., Mannelli, L. D. C., Lucarini, E., Schepetkin, I. A., et al. (2021) · Molecules · doi:10.3390/molecules26216583 · Cited by 9
Structural and conformational studies of biased agonism through formyl peptide receptors
Liao, Q., & Ye, R. D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00108.2022 · Cited by 9
[Immunometabolism of exercise and sedentary lifestyle].
Moreno‐Eutímio, M. A., & Acosta‐Altamirano, G. (2014) · PubMed · Cited by 12
Wu, C.-H., Li, K., Yu, C., Tsai, C., & Hsieh, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125501 · Cited by 9
Távora, B. D. C. L. F., Kimura, L. F., Antoniazzi, M. M., Chiariello, T. M., Faquim-Mauro, E. L., & Barbaro, K. C. (2016) · Toxicon · doi:10.1016/j.toxicon.2016.08.017 · Cited by 9
What the Journal Would Like to Publish on Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., & Barnes, P. J. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201004-0616ed · Cited by 9
Attenuation of adipose tissue inflammation by pro-resolving lipid mediators
Clark, M., Suur, B. E., Soták, M., & Börgeson, E. (2024) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2024.100539 · Cited by 12
A synergistic multimodality treatment approach to address the key drivers of wound chronicity
Lohr, J. M., Raffetto, J. D., Dexter, D., Regulski, M. J., EDMONDS, M. E., Ozsvath, K. J., & Blakely, M. (2025) · Journal of Vascular Surgery Venous and Lymphatic Disorders · doi:10.1016/j.jvsv.2025.102348 · Cited by 12
“15,16 The inflammatory wound environment is shown in Fig 1, and the wound environment after successful resolution of inflammation is shown in Fig 2.”
Resolution of Cerebral Inflammation Following Subarachnoid Hemorrhage
Patsouris, V., Blecharz-Lang, K. G., Nieminen-Kelhä, M., Schneider, U. C., & Vajkoczy, P. (2023) · Neurocritical Care · doi:10.1007/s12028-023-01770-w · Cited by 10
Surgical inflammatory stress: the embryo takes hold of the reins again
Aller, M., Arias, J. I., Prieto, I., Gilsanz, C., Arias, A., Yang, H., & Árias, J. (2013) · Theoretical Biology and Medical Modelling · doi:10.1186/1742-4682-10-6 · Cited by 9
“Clearly, the mechanisms that promote tissue structuring and function restoration also include those involved in resolving inflammation [68].”
BackgroundDengue and metabolomics in humans
Romagnolo, A. G., & Carvalho, K. I. (2021) · Metabolomics · doi:10.1007/s11306-021-01783-6 · Cited by 7
Metadata
- Authors
- Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L.
- Affiliations
- Brigham and Women's Hospital (US)
- King's College London (GB)
- University of Birmingham (GB)
- University College London (GB)
- Centre for Inflammation Research (GB)
- Trinity College Dublin (IE)
- Queen Mary University of London (GB)
- University of Calgary (CA)
- Corresponding author
- Serhan, Charles N.
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 21
- Issue
- 2
- Pages
- 325-332
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC3119634
- OpenAlex
- W2120699390
- Cited by
- 1,045
- References
- 36
- Citations by year
- 2026: 20 · 2025: 26 · 2024: 30 · 2023: 46 · 2022: 42 · 2021: 59 · 2020: 70 · 2019: 53 · 2018: 57 · 2017: 59 · 2016: 57 · 2015: 66 · 2014: 65 · 2013: 90 · 2012: 74
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Norges Idrettshøgskole
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- inflammation resolution, acute inflammation, anti-inflammatory agents, inflammation-associated diseases
- MeSH terms
- Animals, Anti-Inflammatory Agents, Humans, Inflammation, Leukocytes, Models, Biological, Cytokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.